A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified October 2014 by Oncoceutics, Inc.
Sponsor:
Information provided by (Responsible Party):
Oncoceutics, Inc.
ClinicalTrials.gov Identifier:
NCT02038699
First received: January 14, 2014
Last updated: October 14, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)